Bridging therapy in antiphospholipid syndrome and antiphospholipid antibodies carriers: Case series and review of the literature

Autoimmunity Reviews

Volumn 14, Issue 1, 2015, Pages 36-42

  Raso, Samuele ^a   Sciascia, Savino ^b,c   Kuzenko, Anna ^a   Castagno, Irene ^a   Marozio, Luca ^b   Bertero, Maria Tiziana ^a  

^a Clinical Immunology   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Anticoagulation; Antiphospholipid syndrome; Bleeding; Bridging therapy; Thrombosis; Warfarin

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PHOSPHOLIPID ANTIBODY; ANTICOAGULANT AGENT; WARFARIN;

ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; BLEEDING; CLINICAL ARTICLE; DEEP VEIN THROMBOSIS; FEMALE; HUMAN; MALE; RETROSPECTIVE STUDY; REVIEW; THROMBOSIS; TREATMENT OUTCOME; TREATMENT RESPONSE; VEIN THROMBOSIS; HEMORRHAGE; IMMUNOLOGY; PERIOPERATIVE PERIOD; RISK FACTOR; THROMBOEMBOLISM;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; HEMORRHAGE; HEPARIN; HUMANS; PERIOPERATIVE PERIOD; RISK FACTORS; THROMBOEMBOLISM; WARFARIN;

EID: 84927565949     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2014.09.002     Document Type: Review

References (30)

1. Baron T.H., Kamath P.S., McBane R.D. Antithrombotic therapy and invasive procedures. N Engl J Med 2013, 369:1079-1080.
2. Reynaud Q., Lega J.C., Mismetti P., Chapelle C., Wahl D., Cathebras P., et al. Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta-analysis. Autoimmun Rev 2014, 13:595-608.
3. Hammerstingl C., Tripp C., Schmidt H., von der Recke G., Omran H. Periprocedural bridging therapy with low-molecular-weight heparin in chronically anticoagulated patients with prosthetic mechanical heart valves: experience in 116 patients from the prospective BRAVE registry. J Heart Valve Dis 2007, 16:285-292.
4. Ortel T.L. Perioperative management of patients on chronic antithrombotic therapy. Hematology Am Soc Hematol Educ Program 2012, 2012:529-535.
5. Patel J.P., Arya R. The current status of bridging anticoagulation. Br J Haematol 2014, 164:619-629.
6. Siegal D., Yudin J., Kaatz S., Douketis J.D., Lim W., Spyropoulos A.C. Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates. Circulation 2012, 126:1630-1639.
7. Spyropoulos A.C., Douketis J.D. How I treat anticoagulated patients undergoing an elective procedure or surgery. Blood 2012, 120:2954-2962.
8. Gallego P., Apostolakis S., Lip G.Y. Bridging evidence-based practice and practice-based evidence in periprocedural anticoagulation. Circulation 2012, 126:1573-1576.
9. Chang H.H., Chiang B.L. The diagnosis and classification of autoimmune coagulopathy: an updated review. Autoimmun Rev 2014, 13:587-590.
10. Comarmond C., Cacoub P. Antiphospholipid syndrome: from pathogenesis to novel immunomodulatory therapies. Autoimmun Rev 2013, 12:752-757.
11. Ruiz-Irastorza G., Crowther M., Branch W., Khamashta M.A. Antiphospholipid syndrome. Lancet 2010, 376:1498-1509.
12. Erkan D., Aguiar C.L., Andrade D., Cohen H., Cuadrado M.J., Danowski A., et al. 14th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends. Autoimmun Rev 2014, 13:685-696.
13. Erkan D., Leibowitz E., Berman J., Lockshin M.D. Perioperative medical management of antiphospholipid syndrome: hospital for special surgery experience, review of literature, and recommendations. J Rheumatol 2002, 29:843-849.
14. Akkara Veetil B.M., Bongartz T. Perioperative care for patients with rheumatic diseases. Nat Rev Rheumatol 2012, 8:32-41.
15. Bazzan M., Vaccarino A., Stella S., Bertero M.T., Carignola R., Montaruli B., et al. Thrombotic recurrences and bleeding events in APS vascular patients: a review from the literature and a comparison with the APS Piedmont Cohort. Autoimmun Rev 2013, 12:826-831.
16. Pengo V., Banzato A., Denas G., Jose S.P., Bison E., Hoxha A., et al. Correct laboratory approach to APS diagnosis and monitoring. Autoimmun Rev 2013, 12:832-834.
17. Miyakis S., Lockshin M.D., Atsumi T., Branch D.W., Brey R.L., Cervera R., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006, 4:295-306.
18. Tosetto A., Castaman G., Rodeghiero F. Bleeders, bleeding rates, and bleeding score. J Thromb Haemost 2013, 11(Suppl. 1):142-150.
19. Sciascia S., Cosseddu D., Montaruli B., Kuzenko A., Bertero M.T. Risk Scale for the diagnosis of antiphospholipid syndrome. Ann Rheum Dis 2011, 70:1517-1518.
20. Pengo V. ISTH guidelines on lupus anticoagulant testing. Thromb Res 2012, 130(Suppl. 1):S76-S77.
21. Sciascia S., Lopez-Pedrera C., Roccatello D., Cuadrado M.J. Catastrophic antiphospholipid syndrome (CAPS). Best Pract Res Clin Rheumatol 2012, 26:535-541.
22. Ramagopalan S.V., Wotton C.J., Handel A.E., Yeates D., Goldacre M.J. Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study. BMC Med 2011, 9:1.
23. Tosetto A., Iorio A., Marcucci M., Baglin T., Cushman M., Eichinger S., et al. Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH). J Thromb Haemost 2012, 10:1019-1025.
24. Ateka-Barrutia O., Khamashta M.A. The challenge of pregnancy for patients with SLE. Lupus 2013, 22:1295-1308.
25. Sibai B.M., Caritis S.N., Thom E., Shaw K., McNellis D. Low-dose aspirin in nulliparous women: safety of continuous epidural block and correlation between bleeding time and maternal-neonatal bleeding complications. National Institute of Child Health and Human Developmental Maternal-Fetal Medicine Network. Am J Obstet Gynecol 1995, 172:1553-1557.
26. Horlocker T.T., Wedel D.J., Benzon H., Brown D.L., Enneking F.K., Heit J.A., et al. Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Reg Anesth Pain Med 2003, 28:172-197.
27. Galli M., Luciani D., Bertolini G., Barbui T. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 2003, 101:1827-1832.
28. Stolz E., Valdueza J.M., Grebe M., Schlachetzki F., Schmitt E., Madlener K., et al. Anemia as a risk factor for cerebral venous thrombosis? An old hypothesis revisited Results of a prospective study. J Neurol 2007, 254:729-734.
29. da Silveira A.D., Ribeiro R.A., Rossini A.P., Stella S.F., Ritta H.A., Stein R., et al. Association of anemia with clinical outcomes in stable coronary artery disease. Coron Artery Dis 2008, 19:21-26.
30. Blanco M., Castillo J. Stroke in 2012: major advances in the treatment of stroke. Nat Rev Neurol 2013, 9:68-70.